Adjunctive electroacupuncture to facilitate discontinuation of non-benzodiazepine hypnotics in chronic insomnia: a randomized controlled trial protocol - Report - MDSpire
Advertisement
Adjunctive electroacupuncture to facilitate discontinuation of non-benzodiazepine hypnotics in chronic insomnia: a randomized controlled trial protocol
Clinical Report: Electroacupuncture for Discontinuation of Non-Benzodiazepines
Overview
This report outlines a randomized controlled trial aimed at evaluating the efficacy and safety of electroacupuncture as an adjunctive therapy for reducing non-benzodiazepine hypnotics use in patients with chronic insomnia disorder. The study seeks to address a significant gap in current insomnia management strategies.
Background
Incorporate statistics or references to support claims about CID prevalence and impact.
Data Highlights
This study will enroll 78 adults with chronic insomnia disorder, comparing electroacupuncture to sham treatment over a 6-week tapering protocol for NBZDs.
Key Findings
The trial will assess the successful discontinuation rate of NBZDs as the primary outcome.
Secondary outcomes include subjective sleep scales, objective sleep parameters, and daytime functioning assessments.
Participants will receive electroacupuncture three times per week at predefined acupoints.
Safety will be monitored through systematic documentation of adverse events.
This study aims to provide high-quality evidence for integrating electroacupuncture into insomnia management.
Clinical Implications
The findings from this trial may support the use of electroacupuncture as a low-risk, non-pharmacological option for patients seeking to discontinue NBZDs. This could enhance current treatment protocols for chronic insomnia and improve patient outcomes.
Conclusion
This trial represents a significant step towards validating electroacupuncture as an adjunctive therapy in the management of chronic insomnia disorder, potentially offering a safer alternative to pharmacological treatments.
